We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Guidance on acetic acid (also known as ethanoic acid) for use in responding to chemical incidents.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Who you should contact if a pet or other animal or human has an unexpected reaction to a veterinary medicine or a problem with a microchip
Information on acetone (also known as propanone) for use in responding to chemical incidents.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
The symptoms, diagnosis, management, surveillance and epidemiology of rubella (German measles).
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Information about acrylamide for use in responding to chemical incidents.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Information on acrylonitrile (2-propenenitrile; cyanoethylene; vinyl cyanide) for use in responding to chemical incidents.
Batch recall alert for human eye gels that may be prescribed by vets and used under the cascade.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).